Omics in Cutaneous Melanoma

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Melanoma is an aggressive, heterogeneous skin cancer influenced by tumor mutations.
• Mutually exclusive mutations and activated alternative signaling pathways intensify carcinogenesis.
• Understanding these molecular drivers is crucial for effective melanoma treatment.

Purpose of the Study:

• To explore the role of omics technologies in understanding melanoma.
• To investigate the impact of transcription factors, growth factors, and microRNAs in melanoma.
• To provide insights into multimodal approaches for identifying melanoma molecular subtypes.

Main Methods:

• Analysis of multidimensional omics data (genomic, transcriptomic, proteomic).
• Identification of mutually exclusive mutations and signaling pathway alterations.
• Evaluation of non-coding RNA (microRNA) as biomarkers.

Main Results:

• Confirmed the significant impact of transcription factors and growth factors on melanoma carcinogenesis.
• Emphasized the role of microRNAs as key biomarkers for tumor characteristics.
• Demonstrated that omics profiling alone is insufficient to assess invasive and metastatic potential.

Conclusions:

• Multidimensional omics technologies are vital for advancing melanoma treatment.
• MicroRNAs are critical determinants of melanoma's biological and molecular profile.
• Multimodal strategies are essential for comprehensive melanoma subtype identification and characterization.